Why should collaboration enhance oncology drug innovation?
Sukhun Kang discusses the importance of collaborating between private and public businesses to increase oncology development
How can public and private healthcare bodies work together to increase innovation in oncology drug development?
In this episode of the Why podcast, Sukhun Kang, an award-winning PhD student at London Business School, answers this question as he discusses his research into oncology drug development. A research project sponsored by the Wheeler Institute for Business and Development He explains how innovation in this field could be transformed and enhanced by greater collaboration – particularly between public bodies and the private sector.
Sukhun Kang is a PhD student in Strategy and Entrepreneurship at London Business School. He’s recently been awarded the school’s prestigious Sir James Ball PhD Prize.
Zoë Stumpf is Head of Thought Leadership & Research Amplification at London Business School.
Discover fresh perspectives and research insights from LBS
